These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21820344)

  • 1. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.
    Strauss KA; Brumbaugh J; Duffy A; Wardley B; Robinson D; Hendrickson C; Tortorelli S; Moser AB; Puffenberger EG; Rider NL; Morton DH
    Mol Genet Metab; 2011; 104(1-2):93-106. PubMed ID: 21820344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
    Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
    Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited Disorders of Lysine Metabolism: A Review.
    Bouchereau J; Schiff M
    J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
    Boy N; Haege G; Heringer J; Assmann B; Mühlhausen C; Ensenauer R; Maier EM; Lücke T; Hoffmann GF; Müller E; Burgard P; Kölker S
    J Inherit Metab Dis; 2013 May; 36(3):525-33. PubMed ID: 22971958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.
    Strauss KA; Donnelly P; Wintermark M
    Brain; 2010 Jan; 133(Pt 1):76-92. PubMed ID: 20032085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
    Hoffmann GF; Athanassopoulos S; Burlina AB; Duran M; de Klerk JB; Lehnert W; Leonard JV; Monavari AA; Müller E; Muntau AC; Naughten ER; Plecko-Starting B; Superti-Furga A; Zschocke J; Christensen E
    Neuropediatrics; 1996 Jun; 27(3):115-23. PubMed ID: 8837070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
    Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
    Prats Viñas J
    Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary practices in glutaric aciduria type 1 over 16 years.
    Gokmen-Ozel H; MacDonald A; Daly A; Ashmore C; Preece MA; Hendriksz C; Vijay S; Chakrapani A
    J Hum Nutr Diet; 2012 Dec; 25(6):514-9. PubMed ID: 22845646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.
    Guerreiro G; Diaz Jaques CE; Wajner M; Vargas CR
    Int J Dev Neurosci; 2020 Feb; 80(1):42-49. PubMed ID: 31910296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
    Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
    Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma.
    Thomas A; Dobbels EFM; Springer PE; Ackermann C; Cotton MF; Laughton B
    Metab Brain Dis; 2018 Apr; 33(2):537-544. PubMed ID: 29427049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
    Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
    Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
    Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
    Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis.
    Couce ML; López-Suárez O; Bóveda MD; Castiñeiras DE; Cocho JA; García-Villoria J; Castro-Gago M; Fraga JM; Ribes A
    Eur J Paediatr Neurol; 2013 Jul; 17(4):383-9. PubMed ID: 23395213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible brain atrophy in glutaric aciduria type 1.
    Numata-Uematsu Y; Sakamoto O; Kakisaka Y; Okubo Y; Oikawa Y; Arai-Ichinoi N; Kure S; Uematsu M
    Brain Dev; 2017 Jun; 39(6):532-535. PubMed ID: 28143689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
    Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
    Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.
    Del Rizzo M; Galderisi A; Celato A; Furlan F; Giordano L; Cazzorla C; Fasan I; Moretti C; Zschocke J; Burlina AB
    Eur J Pediatr; 2016 Aug; 175(8):1123-8. PubMed ID: 26847429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.